Targeting the nucleotide salvage factor DNPH1 sensitizes BRCA-deficient cells to PARP inhibitors.
Science. 2021 Apr 9;372(6538):156-165. doi: 10.1126/science.abb4542.
Science. 2021.
PMID: 33833118
Free PMC article.